Sfoglia per AUTORE
RIVA N
Collezione AOU Novara

  

Items : 8

Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial. in European journal of neurology / Eur J Neurol. 2023 Jan;30(1):69-86. doi: 10.1111/ene.15573. Epub 2022 Oct 7.

2023
AOU Città della Salute di Torino
AOU Novara

Saddi MV; Conte A; Mazzini L; Carboni N; Siciliano G; Florio L; Russo M; Messina S; Simone IL; Sorarù G; Spera C; Filippi M; Riva N; Trojsi F; Zucchi E; Monsurrò MR; Ricciardi D; Simonini C; Tarlarini C; Mandrioli J; Martinelli I; Lunetta C; Spataro R; La Bella V; Logroscino G; Inghilleri M; De Angelis N; Dalla Giacoma S; Ricci C; et alii...

The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations. in Biomedicines / Biomedicines. 2023 Feb 24;11(3):704. doi: 10.3390/biomedicines11030704.

2023
AOU Città della Salute di Torino
AOU Novara

Camu W; Chiò A; On Behalf Of Italsgen Consortium; Lunetta C; Mazzini L; D'Alfonso S; Guy N; Meininger V; Clavelou P; Murru MR; Mandich P; Conforti FL; Zollino M; Sabatelli M; Tarlarini C; Riva N; Tremolizzo L; Giannini F; Mandrioli J; Tanel R; Canosa A; Calvo A; Mora G; Moglia C; Brunetti M; Barberis M; Borghero G; Caponnetto C; Trojsi F; et alii...

Clinical trials in pediatric ALS: a TRICALS feasibility study. in Amyotrophic lateral sclerosis & frontotemporal degeneration / Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7-8):481-488. doi: 10.1080/21678421.2021

2022
AOU Città della Salute di Torino
AOU Novara

Van Den Berg LH; Weber M; Hardiman O; Varona L; VÁzquez Costa JF; Van Leeuwen LAG; Van Damme P; Turner MR; MØller AT; Stevic Z; Svenstrup K; Sarafov S; SorarÙ G; Salachas F; Roes KCB; Rubio MÁ; Riva N; Povedano M; Reviers E; Petri S; Mora JS; Meyer T; Mandrioli J; Mcdermott CJ; Lunetta C; Leigh PN; Kuzma-Kozakiewicz M; Lambert T; De Marchi F; et alii...

Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis. in JAMA neurology / JAMA Neurol. 2021 Oct 1;78(10):1236-1248. doi: 10.1001/jamaneurol.2021.2598.

2021
ASL Cuneo 2
AOU Città della Salute di Torino
AOU Novara

Zollino M; Zucchi E; Volanti P; Vacchiano V; Vita G; Vasta R; Trojsi F; Tranquilli S; Tremolizzo L; Tedeschi G; Ticca A; Torriello A; Spataro R; Tanel R; Simonini C; Sbaiz L; Sideri R; Simone I; Santarelli M; Salvi F; Salivetto M; Riva N; Russo M; Sabatelli M; Salamone P; Riolo G; Ricci C; Quattrini A; Pozzi S; et alii...

Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial. in Journal of neuro-oncology / J Neurooncol. 2019 Jul;143(3):447-455. doi: 10.1007/s11060-019-03175-2. Epub 2019 May 4.

2019
AOU Città della Salute di Torino
AOU Novara

Ricardi U; Bruni A; Scoccianti S; Fusco V; Gatta R; Riva N; Pegurri L; Borghetti P; Pirtoli L; Meduri B; Krengli M; Triggiani L; Turco E; Masini L; Pedretti S; Santoni R; Magrini SM; Buglione M;

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. in Neuron / Neuron. 2018 Mar 21;97(6):1268-1283.e6. doi: 10.1016/j.neuron.2018.02.027.

2018
AOU Novara

Nicolas A; Kenna KP; Renton AE; Ticozzi N; Faghri F; Chia R; Dominov JA; Kenna BJ; Nalls MA; Keagle P; Rivera AM; van Rheenen W; Murphy NA; van Vugt JJFA; Geiger JT; Van der Spek RA; Pliner HA; Shankaracharya; Smith BN; Marangi G; Topp SD; Abramzon Y; Gkazi AS; Eicher JD; Kenna A; Mora G; Calvo A; Mazzini L; Riva N; et alii...

Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial). in BMJ open / BMJ Open. 2017 Aug 11;7(8):e015434. doi: 10.1136/bmjopen-2016-015434.

2017
AOU Città della Salute di Torino
AOU Novara

Silani V; Siciliano G; Rizzi R; Riva N; Mora G; Messina S; Monsurrò MR; Mazzini L; Mandrioli J; Lunetta C; Bella V; Granieri E; Giannini F; Filosto M; Eleopra R; Corbo M; Chiò A; Capasso M; Caponnetto C; Borghero G; Antonini G; Tramacere I; Bella ED; Simone I; Sorarù G; Volanti P; Lauria G;

ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion. in Neurobiology of aging / Neurobiol Aging. 2016 Mar;39:218.e5-8. doi: 10.1016/j.neurobiolaging.2015.11.027. Epub 2015 Dec 8.

2016
AOU Città della Salute di Torino
AOU Novara

Restagno G; D'Alfonso S; Mazzini L; Penco S; Zollino M; Origone P; Murru MR; Battistini S; Capasso M; Tremolizzo L; Tanel R; Mandrioli J; Giannini F; Carrera P; Riva N; Logullo FO; Salvi F; Simone I; Volanti P; La Bella V; Trojsi F; Borghero G; Moglia C; Calvo A; Nalls MA; Johnson JO; Lunetta C; Traynor BJ; Sabatelli M; et alii...